|  | 
| MechanismTubulin inhibitors | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with AxLR, SATT Occitanie Méditerranée SAS
0  Patents (Medical) associated with AxLR, SATT Occitanie Méditerranée SAS
100 Deals associated with AxLR, SATT Occitanie Méditerranée SAS
100 Translational Medicine associated with AxLR, SATT Occitanie Méditerranée SAS